Showing 21,221 - 21,240 results of 31,017 for search '(( significant decrease decrease ) OR ( significantly ((change decrease) OR (change increases)) ))', query time: 0.54s Refine Results
  1. 21221

    Data Sheet 1_Nonlinear association between wet-bulb globe temperature and maternal hypertensive disorders burden: a global analysis from 1990 to 2021.csv by Boya Zhao (5737136)

    Published 2025
    “…Under global warming, heat stress is increasingly implicated in dysregulated blood pressure during pregnancy, yet robust global-scale evidence remains limited.…”
  2. 21222

    Table 1_Temporal and geographical dynamics of early-onset Parkinson’s disease burden: insights from the Global Burden of Disease Study 2021.docx by Yong Li (15029)

    Published 2025
    “…</p>Results<p>The global incidence of EOPD saw a significant increase between 2000 and 2009, with an average annual percentage change (AAPC) of 4.3%, continuing at a slower rate (AAPC 1.6%) from 2010 to 2021. …”
  3. 21223

    Supporting data for "Dual-function peptides carrying defective interfering genes against influenza virus". by Xinjie Meng (14310011)

    Published 2025
    “…To enhance the efficiency of DIG transfection in vitro and in vivo, a dual-functional peptide, TAT2-P1-LAH4, was identified; this peptide can form a uniform spherical nanoparticle, smaller than 140 nanometres, that effectively increases DIG expression in the lung airways. The 7A8DF peptide series, which enabled efficient gene delivery, inhibited conformational changes in hemagglutinin by binding to it and preventing the virus from infecting cells. …”
  4. 21224

    Effect of Hyperketonemia on Myocardial Function in Patients with Heart Failure and Type 2 Diabetes by Carolina Solis-Herrera (18183399)

    Published 2024
    “…Cardiac output, LVEF, and stroke volume increased significantly during b-OH-B infusion in Groups II (CO, 4.54 to 5.30; EF, 39.9 to 43.8; SV, 70.3 to 80.0) and III (CO, 5.93 to 7.16; EF, 41.1 to 47.5; SV, 89.0 to 108.4) and did not change with NaHCO3 infusion in Group II. …”
  5. 21225

    Multibeam data for optogenetic activation of dFB<sup>VGlutՈ84C10</sup> and dFB<sup>ChATՈ84C10</sup> neurons at 50 Hz. by Joseph D. Jones (13883524)

    Published 2025
    “…Two-way ANOVA followed by Sidak’s multiple comparisons revealed that activating 84C10-AD; ChAT-DBD neurons significantly increases total sleep. n.s. = not significant, ****<i>P</i> < 0.0001. …”
  6. 21226

    Image 6_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway in... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  7. 21227

    Image 2_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway in... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  8. 21228

    Image 5_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway in... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  9. 21229

    Image 10_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway i... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  10. 21230

    Image 9_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway in... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  11. 21231

    Image 8_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway in... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  12. 21232

    Image 4_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway in... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  13. 21233

    Image 1_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway in... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  14. 21234

    Image 7_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway in... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  15. 21235

    Image 3_Transcutaneous auricular vagus nerve stimulation alleviates inflammation-induced depression by modulating peripheral-central inflammatory cytokines and the NF-κB pathway in... by Xingke Song (21372995)

    Published 2025
    “…</p>Results<p>Behavioral tests demonstrated that LPS-induced rats exhibited significant depressive-like behaviors, including reduced sucrose preference, decreased activity levels in the open field, and restricted exploratory behavior in the elevated plus maze. taVNS intervention significantly alleviated these depressive-like behaviors. …”
  16. 21236

    Dynamic-stress induced elastic weakening and healing in jammed granular materials. by Wenrui Yang (4616332)

    Published 2025
    “…Our experimental results show that following an initial weakening, sustained dynamic excitation drives significant dynamic healing without obvious sample volume change. …”
  17. 21237

    Data Sheet 4_Global, regional, and national burden of musculoskeletal disorders, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2035.pdf by Meizhi Liu (21898892)

    Published 2025
    “…</p>Results<p>In 2021, 1.686 billion MSDs prevalent cases were recorded globally, representing a 95% increase since 1990. Although total cases and DALYs have increased, ASIR and ASMR showed declining trends, with global MSD-related mortality decreasing by 0.265% annually. …”
  18. 21238

    Table 3_Global, regional, and national burden of musculoskeletal disorders, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2035.doc by Meizhi Liu (21898892)

    Published 2025
    “…</p>Results<p>In 2021, 1.686 billion MSDs prevalent cases were recorded globally, representing a 95% increase since 1990. Although total cases and DALYs have increased, ASIR and ASMR showed declining trends, with global MSD-related mortality decreasing by 0.265% annually. …”
  19. 21239

    Data Sheet 3_Global, regional, and national burden of musculoskeletal disorders, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2035.pdf by Meizhi Liu (21898892)

    Published 2025
    “…</p>Results<p>In 2021, 1.686 billion MSDs prevalent cases were recorded globally, representing a 95% increase since 1990. Although total cases and DALYs have increased, ASIR and ASMR showed declining trends, with global MSD-related mortality decreasing by 0.265% annually. …”
  20. 21240

    Data Sheet 10_Global, regional, and national burden of musculoskeletal disorders, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2035.pdf by Meizhi Liu (21898892)

    Published 2025
    “…</p>Results<p>In 2021, 1.686 billion MSDs prevalent cases were recorded globally, representing a 95% increase since 1990. Although total cases and DALYs have increased, ASIR and ASMR showed declining trends, with global MSD-related mortality decreasing by 0.265% annually. …”